• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

SLIT vs SCIT: A Q&A

by Pippa Wysong • February 1, 2009

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Dr. Marple: In the US there was use of the sublingual approach by homeopaths, but the doses were quite low, and the studies relating to it weren’t of high quality. The doses being used in Europe were much higher and approximated those that were being given by subcutaneous routes. Over the past decade, rigorous clinical trials have demonstrated that when delivered in adequate doses, this was a viable form of antigen delivery. Now, SLIT is becoming more mainstream in the US.

You Might Also Like

  • Sublingual Immunotherapy (SLIT) Quality of Life Outcomes
  • SCIT Effective for Asthma, Allergic Rhinitis
  • Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis
  • FDA Approves First Sublingual Allergy Immunotherapy Agents
Explore This Issue
February 2009

How effective is SLIT compared with SCIT? How do the safety profiles compare?

Dr. Marple: The efficacy from this different route of delivery for immunotherapy appears in most outcome studies to be roughly equivalent to subcutaneous IT. While some studies fail to show significant benefit, a recent Cochrane meta-analysis demonstrated efficacy in control of rhinitis symptoms in patients older than 12 years. Further, there was a trend suggesting that better results were seen in studies that made use of higher doses of antigen, suggesting that total dose of antigen is important. Conversely, insufficient pediatric data were available to make an assessment. The huge difference is in the safety profile. This appears to be much safer than subcutaneous IT.

Steven Levine, MDI think that this is an outstanding alternative for patients who would otherwise not want to go through injection immunotherapy. They can avoid the needles and the inconvenience of having to come into the office as much.
-Steven Levine, MD

Dr. Morris: A Scandanavian study compared the effectiveness and safety of injection therapy with SLIT using birch pollen antigens. It was a placebo-controlled, double-blind, double-dummy trial. Both therapies showed superiority over placebo, and statistically there was no difference between subcutaneous and sublingual in terms of efficacy. However, safety was markedly better with sublingual. It’s the best-designed study we’ve had on this.

Are the same antigens used for SCIT and SLIT?

Dr. Levine: Yes. You have the same variety, and you can treat patients with a larger number of antigens using drops [SLIT] compared to the shots. With individual injections, there are limitations to what we normally mix together. For instance, some like to keep the mold antigens separate from the trees, grasses, and leaves. Others might want to keep dust separate from the animal antigens. And there is a limitation to how many injections patients will tolerate. Many will limit it to four injections, plus limit the number of antigens in each one of these injections. This is all in an effort to reduce adverse reactions. However, with SLIT there are so few reactions, we can actually use more antigens simultaneously safely. Typically, in our practice, we’ll mix as many as 20 antigens in a single bottle.

Does using SLIT require much training?

Dr. Marple: I would not like to lose sight of the fact that this is one component of the overall management of allergic patients. Many otolaryngologists provide care for allergic patients, and manage them in their office. This is being taught in residency programs as mandated by ACGME. SLIT is one new tool in the overall management of allergic rhinitis, and is best incorporated into your practice after you’ve spent some time learning specifically about it. That being said, it’s relatively straightforward and not overly difficult. Also, patients benefit from it.

Mary Morris, MDThe knowledge needed is quite similar to what you need to know for subcutaneous injection; it’s basically knowing how to mix up the treatment vials for the sublingual version.
-Mary Morris, MD

Dr. Morris: The American Academy of Otolaryngic Allergy has a protocol and is teaching courses. Plus, courses are taught by private clinics and other associations. It shouldn’t be difficult to find training. The knowledge needed is quite similar to what you need to know for subcutaneous injection; it’s basically knowing how to mix up the treatment vials for the sublingual version.

How are patients selected for SLIT verses traditional IT?

Dr. Levine: Doctors should continue with the gold standard, which is injection therapy. At the same time, what I can tell you from my clinical experience of having done this now for about six years, is I think that this is an outstanding alternative for patients who would otherwise not want to go through injection immunotherapy. They can avoid the needles and the inconvenience of having to come into the office as much.

Pages: 1 2 3 | Single Page

Filed Under: Head and Neck, Laryngology Tagged With: patient safety, patient satisfaction, subcutaneous immunotherapy, Sublingual immunotherapyIssue: February 2009

You Might Also Like:

  • Sublingual Immunotherapy (SLIT) Quality of Life Outcomes
  • SCIT Effective for Asthma, Allergic Rhinitis
  • Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis
  • FDA Approves First Sublingual Allergy Immunotherapy Agents

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939